Cite
Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy.
MLA
Malyszko, Jolanta, et al. “Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy.” Kidney & Blood Pressure Research, vol. 32, no. 4, Oct. 2009, pp. 235–38. EBSCOhost, https://doi.org/10.1159/000235747.
APA
Malyszko, J., Malyszko, J. S., & Mysliwiec, M. (2009). Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy. Kidney & Blood Pressure Research, 32(4), 235–238. https://doi.org/10.1159/000235747
Chicago
Malyszko, Jolanta, Jacek S. Malyszko, and Michal Mysliwiec. 2009. “Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy.” Kidney & Blood Pressure Research 32 (4): 235–38. doi:10.1159/000235747.